Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
Add more filters










Publication year range
1.
Oncogene ; 31(46): 4859-67, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-22266870

ABSTRACT

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in neuroblastoma, a devastating pediatric cancer of the sympathetic nervous system. Germline and somatically acquired ALK aberrations induce increased autophosphorylation, constitutive ALK activation and increased downstream signaling. Thus, ALK is a tractable therapeutic target in neuroblastoma, likely to be susceptible to both small-molecule tyrosine kinase inhibitors and therapeutic antibodies-as has been shown for other receptor tyrosine kinases in malignancies such as breast and lung cancer. Small-molecule inhibitors of ALK are currently being studied in the clinic, but common ALK mutations in neuroblastoma appear to show de novo insensitivity, arguing that complementary therapeutic approaches must be developed. We therefore hypothesized that antibody targeting of ALK may be a relevant strategy for the majority of neuroblastoma patients likely to have ALK-positive tumors. We show here that an antagonistic ALK antibody inhibits cell growth and induces in vitro antibody-dependent cellular cytotoxicity of human neuroblastoma-derived cell lines. Cytotoxicity was induced in cell lines harboring either wild type or mutated forms of ALK. Treatment of neuroblastoma cells with the dual Met/ALK inhibitor crizotinib sensitized cells to antibody-induced growth inhibition by promoting cell surface accumulation of ALK and thus increasing the accessibility of antigen for antibody binding. These data support the concept of ALK-targeted immunotherapy as a highly promising therapeutic strategy for neuroblastomas with mutated or wild-type ALK.


Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Neuroblastoma/immunology , Neuroblastoma/therapy , Receptor Protein-Tyrosine Kinases/antagonists & inhibitors , Receptor Protein-Tyrosine Kinases/immunology , Anaplastic Lymphoma Kinase , Antigens, Neoplasm/genetics , Antigens, Neoplasm/immunology , Antigens, Neoplasm/metabolism , Cell Death/drug effects , Cell Death/genetics , Cell Death/immunology , Cell Line, Tumor , Cell Proliferation/drug effects , Crizotinib , Humans , Mutation/immunology , Neuroblastoma/genetics , Neuroblastoma/metabolism , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Protein-Tyrosine Kinases/genetics , Protein-Tyrosine Kinases/immunology , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins c-met/antagonists & inhibitors , Pyrazoles/pharmacology , Pyridines/pharmacology , Receptor Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases/metabolism , Signal Transduction/drug effects , Signal Transduction/immunology
2.
Oncogene ; 26(11): 1567-76, 2007 Mar 08.
Article in English | MEDLINE | ID: mdl-16953218

ABSTRACT

Several somatic mutations within the tyrosine kinase domain of epidermal growth factor receptor (EGFR) have been identified that predict clinical response of non-small-cell lung carcinoma (NSCLC) patients to gefitinib. To test the hypothesis that these mutations cause constitutive EGF receptor signaling, and to investigate its mechanistic basis, we expressed representative examples in a null background and analysed their biochemical properties. Each mutation caused significant EGF-independent tyrosine phosphorylation of EGFR, and allowed the receptor to promote Ba/F3 cell mitogenesis in the absence of EGF, arguing that these are oncogenic mutations. Active mutated receptors are present at the cell surface and are fully competent to bind EGF. Recent structural studies show that the inactive EGFR tyrosine kinase domain is autoinhibited by intramolecular interactions between its activation loop and alphaC helix. We find that mutations predicted to disrupt this autoinhibitory interaction (including several that have not been described in NSCLC) elevate EGF-independent tyrosine kinase activity, thus providing new insight into how somatic mutations activate EGFR and other ErbB family members.


Subject(s)
Antineoplastic Agents/pharmacology , Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Lung Neoplasms/metabolism , Mutation , Quinazolines/pharmacology , Cell Line, Tumor , Cell Membrane/metabolism , Cell Proliferation , ErbB Receptors/chemistry , Gefitinib , Humans , Interleukin-3/pharmacology , Lung Neoplasms/pathology , Models, Molecular , Phosphorylation , Protein Binding
3.
Biochem Soc Trans ; 32(Pt 5): 707-11, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15493994

ABSTRACT

PH domains (pleckstrin homology domains) are the 11th most common domain in the human genome and are best known for their ability to target cellular membranes by binding specifically to phosphoinositides. Recent studies in yeast have shown that, in fact, this is a property of only a small fraction of the known PH domains. Most PH domains are not capable of independent membrane targeting, and those capable of doing so (approx. 33%) appear, most often, to require both phosphoinositide and non-phosphoinositide determinants for their subcellular localization. Several recent studies have suggested that small GTPases such as ARF family proteins play a role in defining PH domain localization. Some others have described a signalling role for PH domains in regulating small GTPases, although phosphoinositides may also play a role. These findings herald a change in our perspective of PH domain function, which will be significantly more diverse than previously supposed.


Subject(s)
Blood Proteins/chemistry , Phosphatidylinositols/chemistry , Phosphoproteins/chemistry , Amino Acid Sequence , Animals , Binding Sites , Cell Membrane/metabolism , Genome , Humans , Models, Molecular , Molecular Sequence Data , Protein Binding , Protein Structure, Tertiary , Saccharomyces cerevisiae/metabolism , Sequence Homology, Amino Acid
4.
J Biol Chem ; 276(49): 45868-75, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-11577097

ABSTRACT

Normally, Rho GTPases are activated by the removal of bound GDP and the concomitant loading of GTP catalyzed by members of the Dbl family of guanine nucleotide exchange factors (GEFs). This family of GEFs invariantly contain a Dbl homology (DH) domain adjacent to a pleckstrin homology (PH) domain, and while the DH domain usually is sufficient to catalyze nucleotide exchange, possible roles for the conserved PH domain remain ambiguous. Here we demonstrate that the conserved PH domains of three distinct Dbl family proteins, intersectin, Dbs, and Tiam1, selectively bind lipid vesicles only when phosphoinositides are present. While the PH domains of intersectin and Dbs promiscuously bind several multiphosphorylated phosphoinositides, Tiam1 selectively interacts with phosphatidylinositol 3-phosphate (K(D) approximately 5-10 microm). In addition, and in contrast to recent reports, catalysis of nucleotide exchange on nonprenylated Rac1 provided by various extended portions of Tiam1 is not influenced by (a) soluble phosphoinositide head groups, (b) dibutyl versions of phosphoinositides, or (c) lipid vesicles containing phosphoinositides. Likewise, GEF activity afforded by DH/PH fragments of intersectin and Dbs are also not altered by phosphoinositide interactions. These results strongly suggest that unless all relevant components are localized to a lipid membrane surface, Dbl family GEFs generally are not intrinsically modulated by binding phosphoinositides.


Subject(s)
Adaptor Proteins, Vesicular Transport , Carrier Proteins/metabolism , Guanine Nucleotide Exchange Factors/metabolism , Phosphatidylinositols/metabolism , Proteins/metabolism , Immunoblotting , Protein Binding , Rho Guanine Nucleotide Exchange Factors , Surface Plasmon Resonance , T-Lymphoma Invasion and Metastasis-inducing Protein 1
5.
J Biol Chem ; 276(47): 44179-84, 2001 Nov 23.
Article in English | MEDLINE | ID: mdl-11557775

ABSTRACT

Phox homology (PX) domains are named for a 130-amino acid region of homology shared with part of two components of the phagocyte NADPH oxidase (phox) complex. They are found in proteins involved in vesicular trafficking, protein sorting, and lipid modification. It was recently reported that certain PX domains specifically recognize phosphatidylinositol 3-phosphate (PtdIns-3-P) and drive recruitment of their host proteins to the cytoplasmic leaflet of endosomal and/or vacuolar membranes where this phosphoinositide is enriched. We have analyzed phosphoinositide binding by all 15 PX domains encoded by the Saccharomyces cerevisiae genome. All yeast PX domains specifically recognize PtdIns-3-P in protein-lipid overlay experiments, with just one exception (a significant sequence outlier). In surface plasmon resonance studies, four of the yeast PX domains bind PtdIns-3-P with high (micromolar range) affinity. Although the remaining PX domains specifically recognize PtdIns-3-P, they bind this lipid with only low affinity. Interestingly, many proteins with "low affinity" PX domains are known to form large multimeric complexes, which may increase the overall avidity for membranes. Our results establish that PtdIns-3-P, and not other phosphoinositides, is the target of all PX domains in S. cerevisiae and suggest a role for PX domains in assembly of multiprotein complexes at specific membrane surfaces.


Subject(s)
Phosphatidylinositol Phosphates/metabolism , Saccharomyces cerevisiae/metabolism , Amino Acid Sequence , Molecular Sequence Data , Protein Binding , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid
6.
Biochem Soc Trans ; 29(Pt 4): 377-84, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11497993

ABSTRACT

More than 250 pleckstrin homology (PH) domains have been identified in the human proteome. All PH domains studied to date appear to bind phosphoinositides, most binding only weakly and non-specifically. Members of a small subclass of PH domains show both high affinity and specificity for particular phosphoinositides, and recent structural studies have provided detailed views of these specific interactions. We discuss the architecture of the specific phosphoinositide-binding sites of PH domains, and how selectivity can be modulated by sequence changes.


Subject(s)
Blood Proteins/chemistry , Blood Proteins/metabolism , Phosphatidylinositols/metabolism , Phosphoproteins/chemistry , Phosphoproteins/metabolism , Binding Sites , Humans , Models, Molecular , Phosphatidylinositol 3-Kinases/metabolism , Protein Conformation , Proteome , Sequence Homology, Amino Acid , Substrate Specificity
7.
Biochemistry ; 40(29): 8581-7, 2001 Jul 24.
Article in English | MEDLINE | ID: mdl-11456498

ABSTRACT

FYVE domains are small zinc-finger-like domains found in many proteins that are involved in regulating membrane traffic and have been shown to bind specifically to phosphatidylinositol 3-phosphate (PtdIns-3-P). FYVE domains are thought to recruit PtdIns-3-P effectors to endosomal locations in vivo, where these effectors participate in controlling endosomal maturation and vacuolar protein sorting. We have compared the characteristics of PtdIns-3-P binding by the FYVE domain from Hrs-1 (the hepatocyte growth factor-regulated tyrosine kinase substrate) with those of specific phosphoinositide binding by Pleckstrin homology (PH) domains. Like certain PH domains (such as that from phospholipase C-delta(1)), the Hrs-1 FYVE domain specifically recognizes a single phosphoinositide. However, while phosphoinositide binding by highly specific PH domains is driven almost exclusively by interactions with the lipid headgroup, this is not true for the Hrs-1 FYVE domain. The phospholipase C-delta(1) PH domain shows a 10-fold preference for binding isolated headgroup over its preferred lipid (phosphatidylinositol 4,5-bisphosphate) in a membrane, while the Hrs-1 FYVE domain greatly prefers (more than 50-fold) intact lipid in a bilayer over the isolated headgroup (inositol 1,3-bisphosphate). By contrast with reports for certain PH domains, we find that this preference for membrane binding over interaction with soluble lipid headgroups does not require FYVE domain oligomerization.


Subject(s)
Cation Transport Proteins , Monosaccharide Transport Proteins , Phosphatidylinositol Phosphates/metabolism , Phospholipids/metabolism , Symporters , Zinc Fingers , Binding, Competitive/genetics , Blood Proteins/genetics , Blood Proteins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Glutathione Transferase/genetics , Guanine Nucleotide Exchange Factors , HeLa Cells , Humans , Liposomes/metabolism , Phosphoproteins/genetics , Phosphoproteins/metabolism , Protein Binding/genetics , Protein Structure, Tertiary/genetics , Proteins/genetics , Proteins/metabolism , Recombinant Fusion Proteins/metabolism , Zinc Fingers/genetics
9.
J Biol Chem ; 276(6): 4322-9, 2001 Feb 09.
Article in English | MEDLINE | ID: mdl-11060292

ABSTRACT

Fibroblast growth factors (FGFs) constitute a large family of heparin-binding growth factors with diverse biological activities. FGF9 was originally described as glia-activating factor and is expressed in the nervous system as a potent mitogen for glia cells. Unlike most FGFs, FGF9 forms dimers in solution with a K(d) of 680 nm. To elucidate the molecular mechanism of FGF9 dimerization, the crystal structure of FGF9 was determined at 2.2 A resolution. FGF9 adopts a beta-trefoil fold similar to other FGFs. However, unlike other FGFs, the N- and C-terminal regions outside the beta-trefoil core in FGF9 are ordered and involved in the formation of a 2-fold crystallographic dimer. A significant surface area (>2000 A(2)) is buried in the dimer interface that occludes a major receptor binding site of FGF9. Thus, we propose an autoinhibitory mechanism for FGF9 that is dependent on sequences outside of the beta-trefoil core. Moreover, a model is presented providing a molecular basis for the preferential affinity of FGF9 toward FGFR3.


Subject(s)
Fibroblast Growth Factors/chemistry , Amino Acid Sequence , Binding Sites , Crystallography, X-Ray , Dimerization , Fibroblast Growth Factor 9 , Fibroblast Growth Factors/antagonists & inhibitors , Fibroblast Growth Factors/metabolism , Models, Molecular , Molecular Sequence Data , Protein Conformation , Receptors, Fibroblast Growth Factor/metabolism , Sequence Homology, Amino Acid
10.
Mol Cell ; 6(2): 373-84, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10983984

ABSTRACT

Pleckstrin homology (PH) domains are protein modules of around 120 amino acids found in many proteins involved in cellular signaling. Certain PH domains drive signal-dependent membrane recruitment of their host proteins by binding strongly and specifically to lipid second messengers produced by agonist-stimulated phosphoinositide 3-kinases (PI 3-Ks). We describe X-ray crystal structures of two different PH domains bound to Ins(1,3,4,5)P4, the head group of the major PI 3-K product PtdIns(3,4,5)P3. One of these PH domains (from Grp1) is PtdIns(3,4,5)P3 specific, while the other (from DAPP1/PHISH) binds strongly to both PtdIns(3,4,5)P3 and its 5'-dephosphorylation product, PtdIns(3,4)P2. Comparison of the two structures provides an explanation for the distinct phosphoinositide specificities of the two PH domains and allows us to predict the 3-phosphoinositide selectivity of uncharacterized PH domains.


Subject(s)
Adaptor Proteins, Signal Transducing , Inositol Phosphates/metabolism , Lipoproteins , Phosphatidylinositol 3-Kinases/chemistry , Phosphatidylinositol 3-Kinases/metabolism , Phosphatidylinositols/metabolism , Amino Acid Sequence , Binding Sites , Blood Proteins/chemistry , Blood Proteins/metabolism , Crystallography, X-Ray , Fatty Acids/chemistry , Fatty Acids/metabolism , Hydrogen Bonding , Models, Molecular , Molecular Sequence Data , Protein Structure, Secondary , Sequence Alignment , Sequence Homology, Amino Acid , Signal Transduction , Substrate Specificity , src Homology Domains
11.
EMBO J ; 19(17): 4632-43, 2000 Sep 01.
Article in English | MEDLINE | ID: mdl-10970856

ABSTRACT

Many different growth factor ligands, including epidermal growth factor (EGF) and the neuregulins (NRGs), regulate members of the erbB/HER family of receptor tyrosine kinases. These growth factors induce erbB receptor oligomerization, and their biological specificity is thought to be defined by the combination of homo- and hetero-oligomers that they stabilize upon binding. One model proposed for ligand-induced erbB receptor hetero-oligomerization involves simple heterodimerization; another suggests that higher order hetero-oligomers are 'nucleated' by ligand-induced homodimers. To distinguish between these possibilities, we compared the abilities of EGF and NRG1-beta1 to induce homo- and hetero-oligomerization of purified erbB receptor extracellular domains. EGF and NRG1-beta1 induced efficient homo-oligomerization of the erbB1 and erbB4 extracellular domains, respectively. In contrast, ligand-induced erbB receptor extracellular domain hetero-oligomers did not form (except for s-erbB2-s-erbB4 hetero-oligomers). Our findings argue that erbB receptor extracellular domains do not recapitulate most heteromeric interactions of the erbB receptors, yet reproduce their ligand-induced homo-oligomerization properties very well. This suggests that mechanisms for homo- and hetero-oligomerization of erbB receptors are different, and contradicts the simple heterodimerization hypothesis prevailing in the literature.


Subject(s)
Oncogene Proteins v-erbB/metabolism , Receptor, ErbB-2/metabolism , Dimerization , Epidermal Growth Factor/metabolism , Humans , Protein Binding , Recombinant Proteins/metabolism
12.
Biochem J ; 350 Pt 1: 1-18, 2000 Aug 15.
Article in English | MEDLINE | ID: mdl-10926821

ABSTRACT

Pleckstrin homology (PH) domains are small protein modules of around 120 amino acids found in many proteins involved in cell signalling, cytoskeletal rearrangement and other processes. Although several different protein ligands have been proposed for PH domains, their only clearly demonstrated physiological function to date is to bind membrane phosphoinositides. The PH domain from phospholipase C-delta(1) binds specifically to PtdIns(4,5)P(2) and its headgroup, and has become a valuable tool for studying cellular PtdIns(4,5)P(2) functions. More recent developments have demonstrated that a subset of PH domains recognizes the products of agonist-stimulated phosphoinositide 3-kinases. Fusion of these PH domains to green fluorescent protein has allowed dramatic demonstrations of their independent ability to drive signal-dependent recruitment of their host proteins to the plasma membrane. We discuss the structural basis for this 3-phosphoinoistide recognition and the role that it plays in cellular signalling. PH domains that bind specifically to phosphoinositides comprise only a minority (perhaps 15%) of those known, raising questions as to the physiological role of the remaining 85% of PH domains. Most (if not all) PH domains bind weakly and non-specifically to phosphoinositides. Studies of dynamin-1 have indicated that oligomerization of its PH domain may be important in driving membrane association. We discuss the possibility that membrane targeting by PH domains with low affinity for phosphoinositides could be driven by alteration of their oligomeric state and thus the avidity of their membrane binding.


Subject(s)
Blood Proteins/metabolism , Phosphoproteins/metabolism , Signal Transduction , Amino Acid Sequence , Blood Proteins/chemistry , Cell Membrane/metabolism , Molecular Sequence Data , Phosphatidylinositols/metabolism , Phosphoproteins/chemistry , Protein Conformation , Sequence Homology, Amino Acid
13.
J Biol Chem ; 275(20): 14873-81, 2000 May 19.
Article in English | MEDLINE | ID: mdl-10809731

ABSTRACT

Current studies involve an investigation of the role of the pleckstrin homology (PH) domain in membrane targeting and activation of phospholipase Cbeta(1) (PLCbeta(1)). Here we report studies on the membrane localization of the isolated PH domain from the amino terminus of PLCbeta(1) (PLCbeta(1)-PH) using fluorescence microscopy of a green fluorescent protein fusion protein. Whereas PLCbeta(1)-PH does not localize to the plasma membrane in serum-starved cells, it undergoes a rapid but transient migration to the plasma membrane upon stimulation of cells with serum or lysophosphatidic acid (LPA). Regulation of the plasma membrane localization of PLCbeta(1)-PH by phosphoinositides was also investigated. PLCbeta(1)-PH was found to bind phosphatidylinositol 3-phosphate most strongly, whereas other phosphoinositides were bound with lower affinity. The plasma membrane localization of PLCbeta(1)-PH induced by serum and LPA was blocked by wortmannin pretreatment and by LY294002. In parallel, activation of PLCbeta by LPA was inhibited by wortmannin, by LY294002, or by the overexpression of PLCbeta(1)-PH. Microinjection of betagamma subunits of G proteins in serum-starved cells induced the translocation of PLCbeta(1)-PH to the plasma membrane. These results demonstrate that a cooperative mechanism involving phosphatidylinositol 3-phosphate and the Gbetagamma subunit regulates the plasma membrane localization and activation of PLCbeta(1)-PH.


Subject(s)
Cell Membrane/enzymology , Isoenzymes/chemistry , Isoenzymes/metabolism , Phosphatidylinositols/metabolism , Type C Phospholipases/chemistry , Type C Phospholipases/metabolism , 3T3 Cells , Androstadienes/pharmacology , Animals , COS Cells , Chromones/pharmacology , Culture Media, Serum-Free , Enzyme Activation , Enzyme Inhibitors/pharmacology , GTP-Binding Proteins/metabolism , Glutathione Transferase/analysis , Green Fluorescent Proteins , Growth Substances/pharmacology , HeLa Cells , Humans , Luminescent Proteins/analysis , Mice , Microscopy, Confocal , Microscopy, Fluorescence , Morpholines/pharmacology , Phospholipase C beta , Polymerase Chain Reaction , Rats , Recombinant Fusion Proteins/analysis , Recombinant Fusion Proteins/metabolism , Transfection , Wortmannin , src Homology Domains
14.
Curr Biol ; 9(5): 261-4, 1999 Mar 11.
Article in English | MEDLINE | ID: mdl-10074457

ABSTRACT

The dynamins are 100 kDa GTPases involved in the scission of endocytic vesicles from the plasma membrane [1]. Dynamin-1 is present in solution as a tetramer [2], and undergoes further self-assembly following its recruitment to coated pits to form higher-order oligomers that resemble 'collars' around the necks of nascent coated buds [1] [3]. GTP hydrolysis by dynamin in these collars is thought to accompany the 'pinching off' of endocytic vesicles [1] [4]. Dynamin contains a pleckstrin homology (PH) domain that binds phosphoinositides [5] [6], which in turn enhance both the GTPase activity [5] [7] [8] and self-assembly [9] [10] of dynamin. We recently showed that the dynamin PH domain binds phosphoinositides only when it is oligomeric [6]. Here, we demonstrate that interactions between the dynamin PH domain and phosphoinositides are important for dynamin function in vivo. Full-length dynamin-1 containing mutations that abolish phosphoinositide binding by its PH domain was a dominant-negative inhibitor of receptor-mediated endocytosis. Mutated dynamin-1 with both a defective PH domain and impaired GTP binding and hydrolysis also inhibited receptor-mediated endocytosis. These findings suggest that the role of the PH domain in dynamin function differs from that seen for other PH domains. We propose that high-avidity binding to phosphoinositide-rich regions of the membrane by the multiple PH domains in a dynamin oligomer is critical for dynamin's ability to complete vesicle budding.


Subject(s)
Blood Proteins/metabolism , Endocytosis/physiology , GTP Phosphohydrolases/metabolism , Phosphoproteins , Binding Sites , Blood Proteins/genetics , Dynamin I , Dynamins , GTP Phosphohydrolases/genetics , Humans , Mutagenesis , Phosphatidylinositol 4,5-Diphosphate/metabolism
16.
J Biol Chem ; 273(46): 30497-508, 1998 Nov 13.
Article in English | MEDLINE | ID: mdl-9804818

ABSTRACT

Pleckstrin homology (PH) domains are small protein modules involved in recruitment of signaling molecules to cellular membranes, in some cases by binding specific phosphoinositides. We describe use of a convenient "dot-blot" approach to screen 10 different PH domains for those that recognize particular phosphoinositides. Each PH domain bound phosphoinositides in the assay, but only two (from phospholipase C-delta1 and Grp1) showed clear specificity for a single species. Using soluble inositol phosphates, we show that the Grp1 PH domain (originally cloned on the basis of its phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding) binds specifically to D-myo-inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) (the PtdIns(3,4,5)P3 headgroup) with KD = 27.3 nM, but binds D-myo-inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) or D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) over 80-fold more weakly. We show that this specificity allows localization of the Grp1 PH domain to the plasma membrane of mammalian cells only when phosphatidylinositol 3-kinase (PI 3-K) is activated. The presence of three adjacent equatorial phosphate groups was critical for inositol phosphate binding by the Grp1 PH domain. By contrast, another PH domain capable of PI 3-K-dependent membrane recruitment (encoded by EST684797) does not distinguish Ins(1,3,4)P3 from Ins(1,3,4,5)P3 (binding both with very high affinity), despite selecting strongly against Ins(1,4,5)P3. The remaining PH domains tested appear significantly less specific for particular phosphoinositides. Together with data presented in the literature, our results suggest that many PH domains bind similarly to multiple phosphoinositides (and in some cases phosphatidylserine), and are likely to be regulated in vivo by the most abundant species to which they bind. Thus, using the same simple approach to study several PH domains simultaneously, our studies suggest that highly specific phosphoinositide binding is a characteristic of relatively few cases.


Subject(s)
Phosphatidylinositols/metabolism , Sequence Homology, Amino Acid , Animals , Binding Sites , Calorimetry , Humans , Inositol Phosphates/metabolism , Isoenzymes/metabolism , Kinetics , Ligands , Mice , Phosphatidylinositol 3-Kinases/metabolism , Phospholipase C delta , Rats , Receptors, Cytoplasmic and Nuclear/metabolism , Structure-Activity Relationship , Type C Phospholipases/metabolism
17.
J Biol Chem ; 273(42): 27725-33, 1998 Oct 16.
Article in English | MEDLINE | ID: mdl-9765310

ABSTRACT

The dynamins are 100-kDa GTPases involved in the scission event required for formation of endocytotic vesicles. The two main described mammalian dynamins (dynamin-1 and dynamin-2) both contain a pleckstrin homology (PH) domain, which has been implicated in dynamin binding to (and activation by) acidic phospholipids, most notably phosphoinositides. We demonstrate that the PH domains of both dynamin isoforms require oligomerization for high affinity phosphoinositide binding. Strong phosphoinositide binding was detected only when the PH domains were dimerized by fusion to glutathione S-transferase, or via a single engineered intermolecular disulfide bond. Phosphoinositide binding specificities agreed reasonably with reported effects of different phospholipids on dynamin GTPase activity. Although they differ in their ability to inhibit rapid endocytosis in adrenal chromaffin cells, the dynamin-1 and dynamin-2 PH domains showed identical phosphoinositide binding specificities. Since oligomerization is required for binding of the dynamin PH domain to phosphoinositides, it follows that PH domain-mediated phosphoinositide binding will favor oligomerization of intact dynamin (which has an inherent tendency to self-associate). We propose that the dynamin PH domain thus mediates the observed cooperative binding of dynamin to membranes containing acidic phospholipids and promotes the self-assembly that is critical for both stimulation of its GTPase activity and its ability to achieve membrane scission.


Subject(s)
Blood Proteins/metabolism , GTP Phosphohydrolases/metabolism , Phosphatidylinositols/metabolism , Phosphoproteins , Protein Conformation , Amino Acid Sequence , Binding Sites , Blood Proteins/chemistry , Dimerization , Dynamin I , Dynamins , GTP Phosphohydrolases/chemistry , GTP Phosphohydrolases/genetics , Glutathione Transferase/genetics , Molecular Sequence Data , Mutagenesis , Phosphatidylinositols/chemistry , Protein Isoforms/chemistry , Protein Isoforms/metabolism , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid
18.
EMBO J ; 17(18): 5374-87, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9736615

ABSTRACT

Phosphatidylinositol 3-kinase (PI3K) mediates a variety of cellular responses by generating PtdIns(3,4)P2 and PtdIns(3,4,5)P3. These 3-phosphoinositides then function directly as second messengers to activate downstream signaling molecules by binding pleckstrin homology (PH) domains in these signaling molecules. We have established a novel assay in the yeast Saccharomyces cerevisiae to identify proteins that bind PtdIns(3,4)P2 and PtdIns(3,4,5)P3 in vivo which we have called TOPIS (Targets of PI3K Identification System). The assay uses a plasma membrane-targeted Ras to complement a temperature-sensitive CDC25 Ras exchange factor in yeast. Coexpression of PI3K and a fusion protein of activated Ras joined to a PH domain known to bind PtdIns(3,4)P2 (AKT) or PtdIns(3,4,5)P3 (BTK) rescues yeast growth at the non-permissive temperature of 37 degreesC. Using this assay, we have identified several amino acids in the beta1-beta2 region of PH domains that are critical for high affinity binding to PtdIns(3,4)P2 and/or PtdIns(3,4,5)P3, and we have proposed a structural model for how these PH domains might bind PI3K products with high affinity. From these data, we derived a consensus sequence which predicts high-affinity binding to PtdIns(3, 4)P2 and/or PtdIns(3,4,5)P3, and we have identified several new PH domain-containing proteins that bind PI3K products, including Gab1, Dos, myosinX, and Sbf1. Use of this assay to screen for novel cDNAs which rescue yeast at the non-permissive temperature should provide a powerful approach for uncovering additional targets of PI3K.


Subject(s)
Fungal Proteins/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphoproteins , Saccharomyces cerevisiae/genetics , Second Messenger Systems/physiology , Amino Acid Sequence , Blood Proteins/genetics , Cell Membrane , Consensus Sequence , Conserved Sequence , Models, Molecular , Mutation , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol Phosphates/metabolism , Protein Binding , Recombinant Fusion Proteins , Sequence Homology, Amino Acid , ras Proteins/physiology
20.
EMBO J ; 17(2): 414-22, 1998 Jan 15.
Article in English | MEDLINE | ID: mdl-9430633

ABSTRACT

Signaling via growth factor receptors frequently results in the concomitant activation of phospholipase C gamma (PLC gamma) and phosphatidylinositol (PI) 3-kinase. While it is well established that tyrosine phosphorylation of PLC gamma is necessary for its activation, we show here that PLC gamma is regulated additionally by the lipid products of PI 3-kinase. We demonstrate that the pleckstrin homology (PH) domain of PLC gamma binds to phosphatidylinositol 3,4,5-trisphosphate [PdtIns(3,4,5)P3], and is targeted to the membrane in response to growth factor stimulation, while a mutated version of this PH domain that does not bind PdtIns(3,4,5)P3 is not membrane targeted. Consistent with these observations, activation of PI 3-kinase causes PLC gamma PH domain-mediated membrane targeting and PLC gamma activation. By contrast, either the inhibition of PI 3-kinase by overexpression of a dominant-negative mutant or the prevention of PLC gamma membrane targeting by overexpression of the PLC gamma PH domain prevents growth factor-induced PLC gamma activation. These experiments reveal a novel mechanism for cross-talk and mutual regulation of activity between two enzymes that participate in the control of phosphoinositide metabolism.


Subject(s)
Blood Proteins/physiology , Isoenzymes/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphoproteins , Type C Phospholipases/metabolism , Amino Acid Sequence , Androstadienes/pharmacology , Animals , Blood Platelets , Blood Proteins/genetics , Blood Proteins/metabolism , COS Cells , Cell Line , Cell Membrane/drug effects , Cell Membrane/enzymology , Cell Membrane/metabolism , Enzyme Activation/drug effects , HeLa Cells , Humans , Isoenzymes/genetics , Molecular Sequence Data , Mutagenesis , Phosphatidylinositol Phosphates/genetics , Phosphatidylinositol Phosphates/metabolism , Phospholipase C gamma , Protein Binding/genetics , Protein Structure, Tertiary , Rats , Signal Transduction , Type C Phospholipases/genetics , Wortmannin
SELECTION OF CITATIONS
SEARCH DETAIL
...